Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), sold 100,000 shares at $93.81 ($9.4M) on 2023-10-26, disclosed to the SEC on 2023-10-30.
Scheduled sale ($9.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.81 | 26,907 | $2.5M | 26.8% |
| 2 | $93.81 | 26,907 | $2.5M | 26.8% |
| 3 | $94.33 | 23,093 | $2.2M | 23.2% |
| 4 | $94.33 | 23,093 | $2.2M | 23.2% |
| Total | $94.05 avg | 100,000 | $9.4M | 100% |
| Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |
| ABT | SELL | 2022-10-31 | $9.7M | — | Filing → |